Koss Olinger Consulting, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Koss Olinger Consulting, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$25.44 - $37.35 $118,932 - $174,611	-4,675 Reduced 33.45%	9,300 $237,000
Q1 2023 May 12, 2023	BUY	$14.72 - $23.97 $205,712 - $334,980	13,975 New	13,975 $334,000
Q4 2021 Feb 07, 2022	SELL	$34.2 - $47.56 $1.5 Million - $2.08 Million	-43,800 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$27.88 - $58.25 $418,200 - $873,750	-15,000 Reduced 25.51%	43,800 $2.09 Million
Q2 2021 Aug 11, 2021	BUY	$25.79 - $42.11 $1 Million - $1.63 Million	38,800 Added 194.0%	58,800 $1.99 Million
Q1 2021 May 14, 2021	BUY	$38.75 - $86.92 $775,000 - $1.74 Million	20,000 New	20,000 $826,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

Stay updated on Koss Olinger Consulting, LLC with notifications on news.